title: Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with overexpression of c-KIT.
authors.affiliation: Department of Oncology, Central Hospital of Bolzano, Bolzano, Italy. rebecca.pedersini@asbz.it
authors.forename: Rebecca
authors.initials: R
authors.lastname: Pedersini
authors.forename: Emanuela
authors.initials: E
authors.lastname: Vattemi
authors.forename: Guido
authors.initials: G
authors.lastname: Mazzoleni
authors.forename: Claudio
authors.initials: C
authors.lastname: Graiff
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000068877:Imatinib Mesylate; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D019009:Proto-Oncogene Proteins c-kit / Q000096:biosynthesis*; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D016879:Salvage Therapy; D018239:Seminoma / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D036542:Tomography, Spiral Computed; D016896:Treatment Outcome; D015854:Up-Regulation
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit